Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)

PHASE3CompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2016

Conditions
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative ColitisIndeterminate Colitis
Interventions
BEHAVIORAL

Home Monitoring

Participants log onto the TELE-IBD website weekly to answer questions about disease symptoms, adherence, side effects, to check body weight and to receive educational content. Participants receive self action plans after each self-testing session. Alerts are generated to the nurse coordinator if certain clinical criteria are met.

BEHAVIORAL

Home Monitoring

Participants log onto the TELE-IBD website every other week to answer questions about disease symptoms, adherence, side effects, to check body weight and to receive educational content. Participants receive self action plans after each self-testing session. Alerts are generated to the nurse coordinator if certain clinical criteria are met.

Trial Locations (1)

21201

University of Maryland, Baltimore

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

collaborator

Vanderbilt University

OTHER

collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

University of Maryland, Baltimore

OTHER

NCT01692743 - Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) | Biotech Hunter | Biotech Hunter